Mei Li, Zhu-Chun Bei, Yongtian Yuan, Baogang Wang, Dongna Zhang, Likun Xu, . . . Yabin Song. (2024). In-cell bioluminescence resonance energy transfer (BRET)-based assay uncovers ceritinib and CA-074 as SARS-CoV-2 papain-like protease inhibitors. Taylor & Francis Group.
Chicago Style (17th ed.) CitationMei Li, Zhu-Chun Bei, Yongtian Yuan, Baogang Wang, Dongna Zhang, Likun Xu, Liangliang Zhao, Qin Xu, and Yabin Song. In-cell Bioluminescence Resonance Energy Transfer (BRET)-based Assay Uncovers Ceritinib and CA-074 as SARS-CoV-2 Papain-like Protease Inhibitors. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationMei Li, et al. In-cell Bioluminescence Resonance Energy Transfer (BRET)-based Assay Uncovers Ceritinib and CA-074 as SARS-CoV-2 Papain-like Protease Inhibitors. Taylor & Francis Group, 2024.